Physician

Melissa L Stenstrom, MD

According to 2025 Medicare claims, Melissa Stenstrom, MD (NPI: 1477745255) practices dermatology in the Rockford, IL market, with the plurality of this provider's patient population coming from Winnebago, IL. This provider's primary affiliated billing organization is SURGICAL SERVICES OF ILLINOIS, SC (NPI: 1932437290; TIN: 204472766) and primary practice location at 61107-3879.

Stenstrom's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 921 traditional Medicare patients, billed 3,255 HCPCS/CPT codes, and received $161,179 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,580 prescription claims across 609 beneficiaries totaling $1,315,041 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 120 records totaling $2,039. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $292,712 to $161,179. In contrast, Part D prescription costs have moved sharply higher in recent years, from $221,213 to $1,315,041. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$146K$293K2015 Medicare payment: $292,712 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $254,963 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $266,064 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $257,852 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $246,299 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $202,338 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $230,445 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $194,421 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $171,118 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $161,179 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159115,628$292,712
20161,1205,892$254,963
20171,1465,973$266,064
20181,1645,568$257,852
20191,2685,370$246,299
20201,2024,647$202,338
20211,3265,064$230,445
20221,1664,438$194,421
20231,0733,935$171,118
20249213,255$161,179

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$658K$1.3M2015 Drug cost: $221,213 (USD; Tot_Drug_Cst)2016 Drug cost: $296,220 (USD; Tot_Drug_Cst)2017 Drug cost: $349,578 (USD; Tot_Drug_Cst)2018 Drug cost: $404,781 (USD; Tot_Drug_Cst)2019 Drug cost: $615,220 (USD; Tot_Drug_Cst)2020 Drug cost: $670,755 (USD; Tot_Drug_Cst)2021 Drug cost: $706,320 (USD; Tot_Drug_Cst)2022 Drug cost: $1,016,442 (USD; Tot_Drug_Cst)2023 Drug cost: $1,090,132 (USD; Tot_Drug_Cst)2024 Drug cost: $1,315,041 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015414996$221,213
20164891,069$296,220
20174921,120$349,578
20184811,115$404,781
20195391,289$615,220
20206151,475$670,755
20216461,553$706,320
20226241,565$1,016,442
20236091,524$1,090,132
20246091,580$1,315,041

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths181205$72
11102Biopsy of related skin growth, first growth203219$63
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more606767$60
17000Destruction of precancer skin growth, 1 growth303357$37
17003Destruction of precancer skin growth, 2-14 growths189613$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa201,680$413,513
Dupixent PenDupilumab912,828$383,411
Cosentyx Unoready PenSecukinumab12336$141,926
Humira(Cf) PenAdalimumab11308$139,814
XolairOmalizumab12336$33,290

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.120$2,039ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Melissa L. Stenstrom, MD?

Tedicare shows public-source Medicare data for Melissa L. Stenstrom, MD (NPI 1477745255), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Melissa L. Stenstrom, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Melissa L. Stenstrom, MD?

Melissa L. Stenstrom, MD is linked to SURGICAL SERVICES OF ILLINOIS, SC (billing NPI 1932437290) in the available physician profile data.

Does Melissa L. Stenstrom, MD have Open Payments data?

Melissa L. Stenstrom, MD has 120 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.